LDN: 4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
LDN is a Ligand Of Interest in 3MDY designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3MDY_LDN_A_1 | 86% | 19% | 0.097 | 0.965 | 1.4 | 2.2 | 5 | 8 | 0 | 0 | 100% | 1 |
| 3MDY_LDN_C_1 | 84% | 20% | 0.101 | 0.963 | 1.52 | 2.03 | 4 | 9 | 0 | 0 | 100% | 1 |
| 3Q4U_LDN_B_1 | 89% | 23% | 0.078 | 0.958 | 1.58 | 1.75 | 7 | 6 | 0 | 0 | 100% | 1 |
| 3MY0_LDN_H_600 | 74% | 24% | 0.142 | 0.973 | 1.25 | 2.01 | 4 | 6 | 0 | 0 | 100% | 1 |
